Clinical Trial Update: Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating vitamin B6 and B12 for movement disorders induced by antipsychotics in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug Induced Movement Disorder Unspecified
• Schizophrenia

Drugs mentioned

• Vitamin B12 (cobalamin) (cobalamin)
• Vitamin B6 (pyridoxine) (pyridoxine)

Snippet

Sponsor: Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara | Conditions: Schizophrenia, Drug Induced Movement Disorder, Unspecified | Phase 2, Phase 3 | Status: UNKNOWN